FDA Approves TEMODAR(R) (temozolomide) as Treatment for Patients With Newly Diagnosed Glioblastoma Multiforme
Study: Mobile phone radiation harms DNA in lab; Laboratory did not prove that mobile phones are health risk
Challenging focus of cancer research: Nobel Prize-winning geneticist wants more emphasis on spotting diseases in earliest stages, less on drugs
Back to Treatment
Back to top
